/content/mofsl-website-adobe/fragments/open-demat-popup

style

hide-in-desktop

BioAge Labs Inc. share price today is $19.9, up -0.92%. The stock opened at $19.575 against the previous close of $20.07, with an intraday high of $19.89 and low of $18.7.

style

pb-0

BioAge Labs Inc.

/content/mofsl-website-adobe/demat-form-fields

style

sticky-block,pt-0

us-stock

style

pt-0

$19.9 -0.0092(-0.92%) BIOA at 13 Mar 2026 12:12 PM Drug Manufacturers - Specialty & Generic

Lowest Today 18.7

Highest Today 19.89

Today’s Open 19.575

Prev. Close 20.07

52 Week High 24.00

52 Week Low 2.88

Day’s Range: Low 18.7 High 19.89

52-Week Range: Low 2.88 High 24.00

BioAge Labs Inc. Institutional Holdings

BioAge Labs Inc. Market Status

Strong Buy: 0

Buy: 0

Hold: 3

Sell: 0

Strong Sell: 1

BioAge Labs Inc. Fundamentals

Market Cap 837.97 M

PB Ratio 3.1555

PE Ratio 1.4747

Enterprise Value 559.33 M

Total Assets 358.23 M

Volume 457748

BioAge Labs Inc. Company Financials

About BioAge Labs Inc. & investment objective

Company Information BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Organisation Drug Manufacturers - Specialty & Generic

Employees 62

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. Kristen Fortney Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*